- Home
- OPRX
as 04-03-2025 4:00pm EST
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | WALTHAM |
| Market Cap: | 84.4M | IPO Year: | N/A |
| Target Price: | $9.06 | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.10 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.78 - $14.13 | Next Earning Date: | 05-13-2025 |
| Revenue: | $92,127,000 | Revenue Growth: | 28.81% |
| Revenue Growth (this year): | 12.12% | Revenue Growth (next year): | 10.87% |
Latest OptimizeRx Corporation News
OPRX Breaking Stock News: Dive into OPRX Ticker-Specific Updates for Smart Investing
Simply Wall St.
5 days ago
OptimizeRx Corporation (NASDAQ:OPRX) is favoured by institutional owners who hold 59% of the company
MT Newswires
7 days ago
OptimizeRx Files $75 Million Mixed Shelf
Insider Monkey
18 days ago
Why OptimizeRx Corp. (OPRX) Soared Last Week?
Simply Wall St.
22 days ago
OptimizeRx Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
GuruFocus.com
22 days ago
OptimizeRx Corp (OPRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Margin Expansion
Thomson Reuters StreetEvents
22 days ago
Q4 2024 OptimizeRx Corp Earnings Call
Zacks
23 days ago
OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates
GlobeNewswire
23 days ago
OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results
Compare OPRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OPRX OptimizeRx Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.